The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives J.L. Boechat, I. Chora, A. Morais, L. Delgado

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease K. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae

SARS-CoV-2 as a trigger of eosinophilic pneumonia M. Araújo, S. Correia, A.L. Lima, M. Costa, I. Neves